These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 6146049)

  • 1. Treatment of cervical dysplasia with bromocriptine.
    Donath EM; Schindler AE
    Lancet; 1984 Jul; 2(8395):157. PubMed ID: 6146049
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized trial of interferon-alpha in cervical dysplasia.
    Gostout BS; Hartmann LC; Suman VJ; Fay NE; Jefferies JA; Morton RF; Gaffey TA; Farr GH; Tschetter LK; Abu-Ghazaleh S; Gallenberg MM; Hatfield AK
    Int J Gynaecol Obstet; 2001 Aug; 74(2):207-10. PubMed ID: 11502303
    [No Abstract]   [Full Text] [Related]  

  • 3. Folic acid and vitamin C in cervical dysplasia.
    Butterworth CE; Norris D
    Am J Clin Nutr; 1983 Feb; 37(2):332-3. PubMed ID: 6823899
    [No Abstract]   [Full Text] [Related]  

  • 4. beta-Carotene and cervical dysplasia trials in Australia.
    Mackerras D; Baghurst P; Fairley C; Irwig L; Weisberg E; Simpson J
    Ann N Y Acad Sci; 1993 Dec; 691():253-4. PubMed ID: 8129305
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-cancer agents. Cream reduces reappearance of cervical lesions.
    TreatmentUpdate; 2000 Feb; 12(1):5-6. PubMed ID: 12125629
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical studies on intravaginal administration of CDDP for dysplasia, carcinoma in situ and microinvasive carcinoma of the uterine cervix].
    Nakayama K; Sano Y; Endo Y; Sato H; Ohyama T; Yamaguchi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):208-14. PubMed ID: 1545173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Proposal for the treatment of cervix dysplasia with immunomodulators].
    Serra GE; Gustavino C; Serra Cervetti GG
    Minerva Ginecol; 1992; 44(1-2):15-8. PubMed ID: 1508378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of dysplasia of the cervical epithelium with an interferon gel.
    Møller BR; Johannesen P; Osther K; Ulmsteen U; Hastrup J; Berg K
    Obstet Gynecol; 1983 Nov; 62(5):625-9. PubMed ID: 6353302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives.
    Butterworth CE; Hatch KD; Gore H; Mueller H; Krumdieck CL
    Am J Clin Nutr; 1982 Jan; 35(1):73-82. PubMed ID: 7064879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cervical intraepithelial neoplasia associated with HSV2. Treatment with human beta interferon].
    Perri D
    Minerva Ginecol; 1992; 44(1-2):39-41. PubMed ID: 1324444
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinico-experimental study of using plant preparations from the flowers of Filipendula ulmaria (L.) Maxim for the treatment of precancerous changes and prevention of uterine cervical cancer].
    Peresun'ko AP; Bespalov VG; Limarenko AI; Aleksandrov VA
    Vopr Onkol; 1993; 39(7-12):291-5. PubMed ID: 7825300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind placebo-controlled phase II trial of the cyclooxygenase-2 inhibitor Celecoxib in the treatment of cervical dysplasia.
    Farley JH; Truong V; Goo E; Uyehara C; Belnap C; Larsen WI
    Gynecol Oncol; 2006 Nov; 103(2):425-30. PubMed ID: 16677697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In defence of women against HPV-infection].
    Blázovics A
    Orv Hetil; 2007 Apr; 148(17):813. PubMed ID: 17452313
    [No Abstract]   [Full Text] [Related]  

  • 14. Subclinical cervicovaginal human papillomavirus infections associated with cervical condylomata and dysplasia. Treatment outcomes.
    Husseinzadeh N; Guoth JG; Jayawardena DS
    J Reprod Med; 1994 Oct; 39(10):777-80. PubMed ID: 7837123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective treatment of a patient with an advanced carcinoma of the cervix with a combination of bromocriptine and aprotinin.
    Guthrie D; Ross WM; Latner AL; Turner GA; Way S
    Br J Clin Pract; 1981 Sep; 35(9):330-2. PubMed ID: 6173053
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term administration of intravaginal dehydroepiandrosterone on regression of low-grade cervical dysplasia--a pilot study.
    Suh-Burgmann E; Sivret J; Duska LR; Del Carmen M; Seiden MV
    Gynecol Obstet Invest; 2003; 55(1):25-31. PubMed ID: 12624548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of recurrent carcinoma of the cervix with bromocriptine.
    Praest J; Klem V
    Br J Obstet Gynaecol; 1986 May; 93(5):519-20. PubMed ID: 3707885
    [No Abstract]   [Full Text] [Related]  

  • 18. Bromocriptine in the management of advanced carcinoma of the cervix.
    Emembolu JO; Ekwempu CC
    Cent Afr J Med; 1987 May; 33(5):117-9. PubMed ID: 3450400
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of retinoic acid on HPV titration and colposcopic changes in Korean patients with dysplasia of the uterine cervix.
    Ahn WS; Lee JM; Namkoong SE; Lee HY; Kim SJ
    J Cell Biochem Suppl; 1997; 28-29():133-9. PubMed ID: 9589358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of a Vaginal Suppository Formulation to Deliver SHetA2 as a Novel Treatment for Cervical Dysplasia.
    Mahjabeen S; Hatipoglu MK; Chandra V; Benbrook DM; Garcia-Contreras L
    J Pharm Sci; 2018 Feb; 107(2):638-646. PubMed ID: 28989018
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.